Videos

© Getty Images

Hired and retired: New appointments in the pharma industry

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes.

© Getty Images

Hires and retires: key appointments in pharma

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma is keeping you in the know with our most recent round-up of important appointments in the pharma industry - including Veranova, Matica Bio and Aldevron.

© Getty Images

New appointments: Who are the movers and shakers in pharma?

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers and shakers in the pharma industry. From Karuna Therapeutics to IO Biotech, we break down the key changes on the pharmaceutical job ladder.

Representatives from pharma, academia and non-profits spoke at the EATRIS conference, May 27 and 28 in Amsterdam, Netherlands

Dispatches from EATRIS Translational Research Conference, Amsterdam

EATRIS: Pharma has a vital role in translational medicine

By Fiona BARRY

When translational medicine researchers recognise the need for pharma industry cash but are wary of handing over drug development to for-profit organisations, how can public-private collaborations bridge the culture gap?

William Reed Business Media Holiday video

Festive Film

Happy Holidays 2014 from William Reed Business Media!

The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!

Catalent commits to ADCs by upping its stake in Redwood

News from Interphex 2014

Catalent commits to ADCs by upping its stake in Redwood

By Dan Stanton

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

Aesica says academic partnerships are key for CMOs

News from CPhI

Aesica says academic partnerships are key for CMOs

By Gareth Macdonald

UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.

Follow us

Webinars

Headlines